Market Wrap: Nifty and Sensex Close in Red Amid Aviation Sector Buzz
Indian stock markets ended in the red on December 16, with Nifty 50 down 0.67% at 25,852.10 and BSE Sensex falling 0.66% to 84,648.12. Market breadth was negative with 2,756 stocks declining versus 1,788 advancing out of 4,544 traded. IndiGo saw significant block trades amidst aviation sector challenges. SEPC Limited secured a major railway infrastructure order. Zydus Lifesciences' subsidiary received FDA acceptance for a potential Menkes disease treatment. Steel Exchange India witnessed a reduction in share pledges.
*this image is generated using AI for illustrative purposes only.
Market Overview
The Indian stock markets closed in negative territory on December 16, 2025, with both benchmark indices, Nifty 50 and BSE Sensex, witnessing declines.
| Index | Closing Price | Change | % Change |
|---|---|---|---|
| Nifty 50 | 25,852.10 | -175.20 | -0.67% |
| BSE Sensex | 84,648.12 | -565.24 | -0.66% |
Market Breadth
The overall market sentiment leaned towards the bearish side, as reflected in the market breadth:
| Category | Number of Scrips |
|---|---|
| Total Traded | 4,544 |
| Positive | 1,788 |
| Negative | 2,756 |
Buzzing Stocks
InterGlobe Aviation (IndiGo)
The company saw significant institutional activity with a block trade worth ₹51.85 crores. However, the aviation sector faces potential challenges as pilot associations legally contest the DGCA's decision on duty time rule exemptions.
SEPC Limited
The infrastructure company secured a major purchase order of ₹269.69 crores from Vishnu Prakash R Punglia Limited for a railway infrastructure project.
Zydus Lifesciences
The company's subsidiary, Sentynl Therapeutics, received FDA acceptance for CUTX-101 NDA resubmission, potentially bringing the first treatment for Menkes disease closer to approval.
Steel Exchange India Ltd
Catalyst Trusteeship Limited released pledged equity shares worth ₹171.60 crores on behalf of debenture holders, reducing encumbrance from 13.76% to nil.
Conclusion
The Indian markets closed lower, with negative breadth indicating broader selling pressure. Key sectors like aviation and infrastructure saw notable developments, while pharmaceutical companies made progress in drug approvals.
18
